Department of Chemical Engineering and Materials Science, University of California, 916 Engineering Tower, Irvine, CA 92697-2575, United States.
Department of Chemical Engineering and Materials Science, University of California, 916 Engineering Tower, Irvine, CA 92697-2575, United States.
Curr Opin Biotechnol. 2014 Aug;28:75-82. doi: 10.1016/j.copbio.2013.12.007. Epub 2014 Jan 8.
Caged protein nanoparticles possess many desirable features for drug delivery, such as ideal sizes for endocytosis, non-toxic biodegradability, and the ability to functionalize at three distinct interfaces (external, internal, and inter-subunit) using the tools of protein engineering. Researchers have harnessed these attributes by covalently and non-covalently loading therapeutic molecules through mechanisms that facilitate release within specific microenvironments. Effective delivery depends on several factors, including specific targeting, cell uptake, release kinetics, and systemic clearance. The innate ability of the immune system to recognize and respond to proteins has recently been exploited to deliver therapeutic compounds with these platforms for immunomodulation. The diversity of drugs, loading/release mechanisms, therapeutic targets, and therapeutic efficacy are discussed in this review.
笼状蛋白纳米颗粒在药物传递方面具有许多理想的特性,例如适合内吞作用的理想尺寸、无毒的生物降解性,以及使用蛋白质工程工具在三个不同界面(外部、内部和亚基间)进行功能化的能力。研究人员通过共价和非共价方式利用这些特性,通过促进在特定微环境中释放的机制来装载治疗分子。有效的传递取决于几个因素,包括特定的靶向、细胞摄取、释放动力学和系统清除率。免疫系统识别和响应蛋白质的固有能力最近被利用来通过这些平台传递免疫调节治疗化合物。本文综述了药物、装载/释放机制、治疗靶点和治疗效果的多样性。